Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of the Somatostatin Analog Sandostatin LAR in Patients With Androgen Independent Prostate Cancer

NCT00510224 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00510224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00510224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of the Somatostatin Analog Sandostatin LAR in Patients With Androgen Independent Prostate Cancer
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2007
Completion date
August 31, 2009
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer